Evidence map›Paper›PMID 35885887›Full record

ArticleGenes2022

A Formative Study of the Implementation of Whole Genome Sequencing in Northern Ireland.

Katie Kerr, Caoimhe McKenna, Shirley Heggarty, Caitlin Bailie, Julie McMullan, Ashleen Crowe, Jill Kilner, Michael Donnelly, Saralynne Boyle, Gillian Rea and 3 more

Open access · goldAbstract read
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Katie KerrCentre for Public Health, Queen's University Belfast, Belfast BT12 6BA, Northern Ireland, UK.ORCID 0000-0002-8469-8885
Caoimhe McKennaCentre for Public Health, Queen's University Belfast, Belfast BT12 6BA, Northern Ireland, UK.
Shirley HeggartyRegional Molecular Diagnostics Service (Germline), Belfast Health and Social Care Trust, Belfast BT9 7AB, Northern Ireland, UK.
Caitlin BailieCentre for Public Health, Queen's University Belfast, Belfast BT12 6BA, Northern Ireland, UK.
Julie McMullanCentre for Public Health, Queen's University Belfast, Belfast BT12 6BA, Northern Ireland, UK.
Ashleen CroweCentre for Public Health, Queen's University Belfast, Belfast BT12 6BA, Northern Ireland, UK.ORCID 0000-0002-4852-4423
Jill KilnerCentre for Public Health, Queen's University Belfast, Belfast BT12 6BA, Northern Ireland, UK.
Michael DonnellyCentre for Public Health, Queen's University Belfast, Belfast BT12 6BA, Northern Ireland, UK.
Saralynne BoyleCentre for Public Health, Queen's University Belfast, Belfast BT12 6BA, Northern Ireland, UK.
Gillian ReaNorthern Ireland Genomic Medicine Centre, Belfast Health and Social Care Trust, Belfast BT9 7AB, Northern Ireland, UK.
Cheryl FlanaganNorthern Ireland Genomic Medicine Centre, Belfast Health and Social Care Trust, Belfast BT9 7AB, Northern Ireland, UK.
Shane McKeeCentre for Public Health, Queen's University Belfast, Belfast BT12 6BA, Northern Ireland, UK.
Amy Jayne McKnightCentre for Public Health, Queen's University Belfast, Belfast BT12 6BA, Northern Ireland, UK.
Queen's University Belfast · GBBelfast Health and Social Care Trust · GB

Funding

Medical Research Council MC_PC_16018
6 · The paper itself

Abstract

Background: The UK 100,000 Genomes Project was a transformational research project which facilitated whole genome sequencing (WGS) diagnostics for rare diseases. We evaluated experiences of introducing WGS in Northern Ireland, providing recommendations for future projects. Methods: This formative evaluation included (1) an appraisal of the logistics of implementing and delivering WGS, (2) a survey of participant self-reported views and experiences, (3) semi-structured interviews with healthcare staff as key informants who were involved in the delivery of WGS and (4) a workshop discussion about interprofessional collaboration with respect to molecular diagnostics. Results: We engaged with >400 participants, with detailed reflections obtained from 74 participants including patients, caregivers, key National Health Service (NHS) informants, and researchers (patient survey n = 42; semi-structured interviews n = 19; attendees of the discussion workshop n = 13). Overarching themes included the need to improve rare disease awareness, education, and support services, as well as interprofessional collaboration being central to an effective, mainstreamed molecular diagnostic service. Conclusions: Recommendations for streamlining precision medicine for patients with rare diseases include administrative improvements (e.g., streamlining of the consent process), educational improvements (e.g., rare disease training provided from undergraduate to postgraduate education alongside genomics training for non-genetic specialists) and analytical improvements (e.g., multidisciplinary collaboration and improved computational infrastructure).

Indexed as

Rare DiseasesState MedicineHumansNorthern IrelandWhole Genome Sequencingcollaborationgenomicsmultiomicspublic healthrare disease

Identifiers

PMID35885887
PMCPMC9316942
OpenAlexW4283278114

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.